Puma Biotechnology Inc Share Price

Puma Biotechnology Inc Share Price

NASDAQ: PBYI | Small Cap
$7.16
-$0.14 (-1.92%) Last updated on 18 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Puma Biotechnology Inc Stock Performance

Open
$7.24
Prev. Close
$7.30
Circuit Range
N/A
Day Range
$6.92 - $7.24
Year Range
$4.79 - $11.37
Volume
24,924
Average Traded
$7.04

Puma Biotechnology Inc Share Price Today

As of 18 November 2026, Puma Biotechnology Inc's share price is $7.16. The stock opened at $7.24, compared to its previous close of $7.30. During today's trading session, Puma Biotechnology Inc's share price traded between $6.92 and $7.24, with an average price of $7.08. Over the past 52 weeks, the stock has recorded a high of $11.37 and a low of $4.79. In terms of performance, Puma Biotechnology Inc's share price has risen by 0.42% over the last six months and is up 41.78% on a year-on-year basis.

Puma Biotechnology Inc Share Price Chart

Line chart of the Puma Biotechnology Inc price trend over the selected period. The price fell overall, ranging from 6.92 to 7.29, ending at 7.16.
$6.92$7.24
L
Show Current Price
H

Puma Biotechnology Inc Stock Fundamentals & Key Indicators

Market Cap
$358.08M
PE Ratio (TTM)
15.92
Dividend Yield
0.00%
EPS (TTM)
$0.46
Revenue (TTM)
$228.37B
Return On Equity (TTM)
16.25%
Profit Margin
13.62%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-55.65%

Puma Biotechnology Inc Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$75.45$44.81$56.50$55.06
Net Profit$13.44-$3.75$8.19$5.96
Net Profit Margin17.81%-8.37%14.50%10.82%
Income ChangeN/A-127.90%318.40%-27.23%

Puma Biotechnology Inc Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$228.03$235.64$230.47$228.37
Net Profit$0.00$21.59$30.28$31.11
Net Profit Margin0.00%9.16%13.14%13.62%
Income ChangeN/AN/A40.25%2.74%

About Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Puma Biotechnology Inc Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$10.44
$7.06
-32.31%
Oct 2026
$9.96
$10.43
+4.98%
Sep 2026
$9.18
$9.94
+7.52%
Aug 2026
$7.84
$9.24
+16.67%
Jul 2026
$8.08
$7.92
-2.22%
Jun 2026
$7.04
$8.10
+13.60%
May 2026
$7.37
$7.13
-4.81%
Apr 2026
$6.46
$7.49
+17.40%
Mar 2026
$5.58
$6.38
+12.23%
Feb 2026
$6.47
$5.68
-12.40%
Jan 2026
$5.81
$6.49
+9.08%
Dec 2025
$4.97
$5.95
+17.82%

PBYI Share Price FAQs